Indeed, antagonism of miR-214 in PAH-PASMC reversed the depressed expression of MEF2C (Fig 7A) and LMOD1 (Fig 7B), suggesting reversion to the contractile phenotype. Here, MEF2C is linked to pulmonary arterial hypertension.